Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity
- 31 March 1984
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 120 (2) , 641-649
- https://doi.org/10.1016/0006-291x(84)91304-4
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranesFEBS Letters, 1983
- Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1Life Sciences, 1983
- Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileumFEBS Letters, 1982
- Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileumFEBS Letters, 1982
- Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP)FEBS Letters, 1981
- Porcine peptide having N‐terminal histidine and C‐terminal isoleucine amide (PHI)FEBS Letters, 1980
- Selective inhibition by somatostatin of cyclic AMP production in rat gastric glandsFEBS Letters, 1980
- Regulation by vasoactive intestinal peptide of cyclic amp accumulation in gastric epithelial glandsFEBS Letters, 1980
- Structure of the vasoactive intestinal octacosapeptide from chicken intestine. The amino acid sequenceFEBS Letters, 1975
- Gut glucagon: A common receptor site with pancreatic glucagon in liver cell plasma membranesFEBS Letters, 1973